Douglas E. Brough
Corporate Officer/Principal bei PRECIGEN, INC.
Profil
Douglas E.
Brough is currently the Senior Vice President & Head-Research at Precigen, Inc. Previously, he worked as the Chief Scientific Officer at GenVec, Inc. from 2013 to 2017.
Dr. Brough holds a doctorate degree from Rutgers State University of New Jersey and Robert Wood Johnson Medical School.
He also has a graduate degree from Idaho State University and an undergraduate degree from Purdue University.
Aktive Positionen von Douglas E. Brough
| Unternehmen | Position | Beginn |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Douglas E. Brough
| Unternehmen | Position | Ende |
|---|---|---|
| GENVEC INC | Technik-/Wissenschafts-/F&E-Leiter | 16.06.2017 |
Ausbildung von Douglas E. Brough
| Purdue University | Undergraduate Degree |
| Idaho State University | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
